Track how many active mutual funds hold diagnostics stocks in India. Monthly data shows where institutional conviction across Dr. Lal Path Labs, Metropolis Healthcare, Thyrocare Technologies, Vijaya Diagnostic Centre, Krsnaa Diagnostics, Suraksha Diagnostic and Vimta Labs is rising or falling.
📅 Updated Jul 2026 · Index funds and ETFs excluded
| # | Stock Name | Apr | May % | Jun % | Jul % | Jul 2026 Funds | Overall % | AUM (₹ Cr) |
|---|---|---|---|---|---|---|---|---|
| 1 | Dr. Lal Path Labs LimitedHealthcare Services | 65 | +9.2% | -5.6% | -3% | 65 | 0% | 5,159 |
| 2 | Metropolis Healthcare LimitedHealthcare Services | 41 | +2.4% | 0% | 0% | 42 | +2.4% | 3,548 |
| 3 | Vijaya Diagnostic Centre LimitedHealthcare Services | 43 | +2.3% | -4.5% | -2.4% | 41 | -4.7% | 4,163 |
| 4 | Thyrocare Technologies LimitedHealthcare Services | 15 | +6.7% | -6.3% | +20% | 18 | +20% | 1,450 |
| 5 | Suraksha Diagnostic LtdHealthcare Services | 7 | +14.3% | 0% | -12.5% | 7 | 0% | 255 |
| 6 | Krsnaa Diagnostics LimitedHealthcare Services | 2 | 0% | 0% | 0% | 2 | 0% | 171 |
| 7 | Vimta Labs LimitedHealthcare Services | — | — | — | -100% | — | — | — |
Diagnostics stocks include listed pathology laboratory chains, imaging centres, and analytical testing companies in India. Dr. Lal Path Labs is one of the largest diagnostic chain in India by revenue, operating a hub-and-spoke network of collection centres and processing labs across the country. Metropolis Healthcare is a leading diagnostics company with a strong presence in metros and tier-two cities offering pathology and radiology services. Thyrocare Technologies is a pioneering low-cost diagnostics company known for thyroid and wellness testing with a franchise-based collection model. Vijaya Diagnostic Centre is a south India focused diagnostics chain with integrated pathology and radiology services. Krsnaa Diagnostics operates a public-private partnership model running diagnostic centres inside government hospitals across multiple states. Suraksha Diagnostic is a diagnostics chain with strong presence in east India particularly West Bengal. Vimta Labs is an analytical and contract research laboratory offering testing services to pharmaceutical and food companies.
Rising fund counts over four months signal growing institutional conviction in the diagnostics sector. Cross-reference individual fund portfolios on our top stocks page or explore full holdings via the funds directory.
India diagnostics sector is structurally underpenetrated relative to its population size, with per capita diagnostic spend well below global averages. The Covid-19 pandemic accelerated awareness of preventive health testing and created lasting demand for regular wellness checkups and home collection services. The shift from unorganised standalone labs to organised branded chains is ongoing, driven by quality standardisation, NABL accreditation requirements, and consumer preference for reliable results. Digital health adoption has made online test booking and home sample collection mainstream, benefiting large chains with technology infrastructure. Government schemes such as Ayushman Bharat are expanding diagnostic access in tier-two and tier-three cities through public-private partnerships, directly benefiting companies like Krsnaa Diagnostics. The aging population and rising incidence of lifestyle diseases such as diabetes, thyroid disorders, and cardiovascular conditions are structural demand drivers for routine diagnostic testing.
For context on SEBI disclosure requirements, refer to AMFI India. For regulatory guidelines, visit SEBI India. Explore broader holding trends using our market cap categories page.
No — all counts exclude index funds, ETFs, and fund of funds. Only actively managed equity mutual funds are counted. Index funds mechanically hold stocks in proportion to index weight — their holdings do not reflect active manager conviction. By excluding them, fund counts here more accurately represent where professional stock pickers are actively building or reducing positions in the India diagnostics and pathology sector.
To explore individual fund portfolios, visit the funds directory or use the SIP calculator to plan investments in funds with high healthcare sector exposure. For a broader market view, see our AAUM data page.